| Date | Title | Description | Source |
| 22.03.2024 | Lynk Pharmaceuticals Announces First Atopic Dermatitis Patie... | BOSTON and HANGZHOU and SHANGHAI, China, March 22, 2024 /PRNewswire/ -- Lynk Pharmaceuticals Co., Lt... | en.prnasia... |
| 20.12.2023 | Lynk Pharmaceuticals Announced First Rheumatoid Arthritis Pa... | BOSTON and HANGZHOU and SHANGHAI, China, Dec. 20, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd... | en.prnasia... |
| 26.09.2023 | Deals in brief: AnyMind Group acquires Indonesia-based DDI, ... | AnyMind Group acquires Digital Distribusi Indonesia
The Singapore-founded brand enablement company h... | kr-asia.co... |
| 21.09.2023 | Lynk Pharmaceuticals Completes Series C2 Financing Round, wi... | HANGZHOU, China, Sept. 21, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred... | en.prnasia... |
| 21.09.2023 | Deals in brief: Bolttech extends Series B round, HSBC launch... | Bolttech extends Series B round to record-breaking USD 246 million
The Singapore-headquartered insur... | kr-asia.co... |
| 21.09.2023 | Lynk Pharmaceuticals Completes Series C2 Financing | Lynk Pharmaceuticals, a Hangzhou, China-based clinical stage company, raised an undisclosed amount i... | finsmes.co... |
| 23.08.2023 | Lynk Pharmaceuticals Announces Positive Topline Data from Ph... | HANGZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (referred to as "... | en.prnasia... |
| 09.08.2023 | Lynk Pharmaceuticals Announced Positive Topline Data from Ph... | HANGZHOU, China, Aug. 9, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred t... | en.prnasia... |
| 21.07.2023 | Lynk Pharmaceuticals Announces First Atopic Dermatitis Patie... | HANGZHOU, China, July 21, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred ... | en.prnasia... |
| 01.06.2023 | Lynk Pharmaceuticals Completes 200M RMB Series C1 Financing | Lynk Pharmaceuticals, a Hangzhou, China-based clinical stage company, raised 200M RMB in Series C1 f... | finsmes.co... |
| 31.05.2023 | Lynk Pharmaceuticals Completes 200 Million RMB Series C1 Fin... | HANGZHOU, China, May 31, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred t... | en.prnasia... |
| 25.05.2023 | Lynk Pharmaceuticals Announces First Cohort of Psoriatic Pat... | HANGZHOU, China, May 25, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred t... | en.prnasia... |
| 16.05.2023 | LYNK's LNK01001 Achieved Exciting Phase II Results in Rheuma... | HANGZHOU, China, May 16, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred t... | en.prnasia... |
| 04.04.2023 | Lynk Pharmaceuticals Announces Positive Results for LNK01003... | HANGZHOU, China, April 4, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred ... | en.prnasia... |
| 05.12.2022 | Lynk Pharmaceuticals Announces First Patient Dosed in Phase ... | HANGZHOU, China, Dec. 5, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred t... | en.prnasia... |
| 03.08.2022 | Lynk Pharmaceuticals Announces IND Approval of LNK01004 for ... | HANGZHOU, China, Aug. 3, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred t... | en.prnasia... |
| 29.07.2022 | Lynk Pharmaceuticals Announces the First Participant Dosed i... | HANGZHOU, China, July 29, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred ... | en.prnasia... |
| 22.04.2022 | Lynk Pharmaceuticals Announces Clinical Approval in China fo... | HANGZHOU, China, April 22, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred... | en.prnasia... |
| 18.03.2022 | Lynk Pharmaceuticals and Simcere announced Strategic Commerc... | HANGZHOU, China, March 18, 2022 /PRNewswire/ -- On March 18, 2022, Lynk Pharmaceuticals Co., Ltd. (L... | en.prnasia... |
| 28.02.2022 | Lynk Pharmaceuticals Announces First Patient Dosed in Phase ... | HANGZHOU, China, Feb. 28, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred ... | en.prnasia... |
| 19.01.2022 | Lynk Pharmaceuticals Announces First Patient Dosed in Phase ... | HANGZHOU, China, Jan. 19, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred ... | en.prnasia... |
| 01.12.2021 | Lynk Pharmaceuticals Announced First Patient Dosed in Phase ... | HANGZHOU, China, Dec. 1, 2021 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred t... | en.prnasia... |
| 07.09.2021 | Digital health news, funding roundup in the prior week; Sept... | Whoop raised $200M and acquired PUSH; Cityblock landed $400M; Eight Sleep secured $86M
Push: Push is... | vator.tv/n... |
| 29.08.2021 | Lynk Pharmaceuticals Closes $50M Series B Financing | Lynk Pharmaceuticals CO., LTD, a Hangzhou, China-based pharmaceutical R&D company, completed Ser... | finsmes.co... |
| 27.08.2021 | Lynk Pharmaceuticals inks $50M series B for 3 early-stage tr... | Lynk Pharmaceuticals picked up $50 million in series B funds Friday to bankroll three assets through... | fiercebiot... |
| 27.08.2021 | Lynk Pharmaceuticals inks $50M series B for 3 early-stage tr... | Lynk Pharmaceuticals picked up $50 million in series B funds Friday to bankroll three assets through... | fiercebiot... |
| 27.08.2021 | Lynk Pharmaceuticals announced the completion of Series B fi... | HANGZHOU, China, Aug. 27, 2021 /PRNewswire/ -- Lynk Pharmaceuticals CO., LTD (hereinafter referred t... | en.prnasia... |
| 12.08.2021 | Lynk Pharmaceuticals Announced First Patient Dosed in Phase ... | HANGZHOU, China, Aug. 12, 2021 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred ... | en.prnasia... |
| 25.06.2021 | Lynk Pharmaceuticals Announced Clinical Approval in China of... | HANGZHOU, China, June 25, 2021 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred ... | en.prnasia... |
| - | LYNK Pharmaceuticals | “Lingke” | fastfounde... |
